Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 20/03/20231 min de lecture
New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA or we) is amending the animal drug regulations to reflect application-related actions for new animal drug applications (NADAs), abbreviated new animal drug applications (ANADAs), and conditionally approved new animal drug applications (cNADAs) during October, November, and December 2022. FDA is informing the public of the availability of summaries of the basis of approval and of environmental review documents, where applicable. The animal drug regulations are also being amended to improve the accuracy and readability of the regulations.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →